PMN
Price
$0.99
Change
+$0.01 (+1.02%)
Updated
Nov 14 closing price
119 days until earnings call
TELIF
Price
$0.31
Change
+$0.02 (+6.90%)
Updated
Nov 14 closing price
Ad is loading...

PMN vs TELIF

Header iconPMN vs TELIF Comparison
Open Charts PMN vs TELIFBanner chart's image
ProMIS Neurosciences
Price$0.99
Change+$0.01 (+1.02%)
Volume$16.28K
CapitalizationN/A
TELESCOPE INNOVATIONS
Price$0.31
Change+$0.02 (+6.90%)
Volume$20K
CapitalizationN/A
PMN vs TELIF Comparison Chart
Loading...
View a ticker or compare two or three
VS
PMN vs. TELIF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMN is a Hold and TELIF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (PMN: $0.99 vs. TELIF: $0.31)
Brand notoriety: PMN and TELIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMN: 21% vs. TELIF: 231%
Market capitalization -- PMN: $29.72M vs. TELIF: $13.81M
PMN [@Biotechnology] is valued at $29.72M. TELIF’s [@Biotechnology] market capitalization is $13.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMN’s FA Score shows that 0 FA rating(s) are green whileTELIF’s FA Score has 0 green FA rating(s).

  • PMN’s FA Score: 0 green, 5 red.
  • TELIF’s FA Score: 0 green, 5 red.
According to our system of comparison, TELIF is a better buy in the long-term than PMN.

Price Growth

PMN (@Biotechnology) experienced а -2.50% price change this week, while TELIF (@Biotechnology) price change was +9.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

PMN is expected to report earnings on Mar 14, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
PMN($29.7M) has a higher market cap than TELIF($13.8M). TELIF YTD gains are higher at: 129.636 vs. PMN (-13.524).
PMNTELIFPMN / TELIF
Capitalization29.7M13.8M215%
EBITDAN/AN/A-
Gain YTD-13.524129.636-10%
P/E RatioN/A85.38-
RevenueN/AN/A-
Total Cash2.5MN/A-
Total Debt4.05MN/A-
FUNDAMENTALS RATINGS
PMN: Fundamental Ratings
PMN
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with BBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
+1.48%
BBIO - PMN
40%
Loosely correlated
-2.74%
ABOS - PMN
29%
Poorly correlated
+3.16%
GALT - PMN
25%
Poorly correlated
-5.17%
LIXT - PMN
25%
Poorly correlated
-2.44%
ARGX - PMN
25%
Poorly correlated
-0.72%
More

TELIF and

Correlation & Price change

A.I.dvisor tells us that TELIF and ATNM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELIF and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELIF
1D Price
Change %
TELIF100%
+5.40%
ATNM - TELIF
28%
Poorly correlated
-3.51%
ELEV - TELIF
24%
Poorly correlated
-6.16%
RVXCF - TELIF
23%
Poorly correlated
+11.32%
TNFA - TELIF
23%
Poorly correlated
-1.65%
PMN - TELIF
20%
Poorly correlated
+1.48%
More